免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

Livongo 血糖监测系统 (BG1000)

K号: K200277 · 2020-06-04

决定日期2020-06-04
产品代码NBW
咨询委员会CH 请注意,您提供的文本“CH”不足以进行翻译。请提供完整的医疗设备监管文本,以便我能够进行准确的翻译。
决定实质等同

器械摘要

Livongo Blood Glucose Monitoring System (BG1000) is the device name listed in this FDA 510(k) record. The listed applicant is Livongo Health, Inc.. It received FDA 510(k) clearance on 2020-06-04 under 510(k) number K200277. The device is classified under product code NBW. It was reviewed by the CH advisory panel. Product code NBW falls under the category of OB/GYN, which includes obstetric and gynecological diagnostic devices. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

常见问题

What is the Livongo Blood Glucose Monitoring System (BG1000)?

Livongo Blood Glucose Monitoring System (BG1000) is a medical device that received FDA 510(k) clearance on 2020-06-04. The listed applicant is Livongo Health, Inc.. The 510(k) number is K200277.

When did Livongo Blood Glucose Monitoring System (BG1000) receive FDA 510(k) clearance?

Livongo Blood Glucose Monitoring System (BG1000) received FDA 510(k) clearance on 2020-06-04, under 510(k) number K200277.

Who is the listed applicant for Livongo Blood Glucose Monitoring System (BG1000)?

The FDA 510(k) record lists Livongo Health, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Livongo Blood Glucose Monitoring System (BG1000)?

The FDA product code for Livongo Blood Glucose Monitoring System (BG1000) is NBW. This falls under the OB/GYN category.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

相关器械(代码:NBW)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑